Your browser doesn't support javascript.
loading
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
Sundar, Sudha; Manchanda, Ranjit; Gourley, Charlie; George, Angela; Wallace, Andrew; Balega, Janos; Williams, Sarah; Wallis, Yvonne; Edmondson, Richard; Nicum, Shibani; Frost, Jonathan; Attygalle, Ayoma; Fotopoulou, Christina; Bowen, Rebecca; Bell, Dani; Gajjar, Ketankumar; Ramsay, Bruce; Wood, Nicholas J; Ghaem-Maghami, Sadaf; Miles, Tracie; Ganesan, Raji.
Afiliação
  • Sundar S; Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UK sudha.sundar@nhs.net.
  • Manchanda R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Gourley C; Gynaecological Oncology, Barts Health NHS Trust, Barts Cancer Institute, London, UK.
  • George A; University of Edinburgh Cancer Research UK Centre, Edinburgh, UK.
  • Wallace A; Royal Marsden Hospital NHS Trust, London, UK.
  • Balega J; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK.
  • Williams S; Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UK.
  • Wallis Y; University Hospital Birmingham Foundation NHS Trust, Birmingham, UK.
  • Edmondson R; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Nicum S; University of Manchester, Manchester, UK.
  • Frost J; Oxford University Hospitals NHS Trust, Oxford, UK.
  • Attygalle A; Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
  • Fotopoulou C; Pathology, Royal Marsden NHS Foundation Trust, London, UK.
  • Bowen R; Gynaecologic Oncology, Imperial Hospitals NHS trust, London, UK.
  • Bell D; Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
  • Gajjar K; Macmillan Cancer Support, London, UK.
  • Ramsay B; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Wood NJ; Peterborough City Hospital, Peterborough, Cambridgeshire, UK.
  • Ghaem-Maghami S; Obstetrics and Gynaecology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
  • Miles T; Imperial College London, London, UK.
  • Ganesan R; Gynaecological Oncology, Royal United Hospitals, Bath, UK.
Int J Gynecol Cancer ; 31(2): 272-278, 2021 02.
Article em En | MEDLINE | ID: mdl-33468564
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 / Carcinoma Epitelial do Ovário Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 / Carcinoma Epitelial do Ovário Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido